Literature DB >> 17500002

Significance of malperfusion syndromes prior to contemporary surgical repair for acute type A dissection: outcomes and need for additional revascularizations.

Arnar Geirsson1, Wilson Y Szeto, Alberto Pochettino, Michael L McGarvey, Martin G Keane, Y Joseph Woo, John G Augoustides, Joseph E Bavaria.   

Abstract

OBJECTIVE: The aim of this study was to assess the significance of malperfusion syndromes in patients with acute type A aortic dissection following a contemporary surgical management algorithm and the effects on morbidity, hospital mortality, and long-term survival. We believe that obliteration of the primary tear site with restoration of flow in the true aortic lumen results in decreased need for revascularization of malperfused organ systems.
METHODS: Our operative approach aims at replacing the entire ascending aorta, resuspension of the aortic valve with repair or replacement of the sinus segment, and routine open replacement of the arch under hypothermic circulatory arrest with retrograde cerebral perfusion with obliteration of false lumen at the distal arch/proximal descending thoracic aorta, thus reestablishing normal flow in the descending thoracic true lumen. From January 1993 to December 2004, 221 consecutive patients underwent repair of acute type A aortic dissection at our institution. Data were collected retrospectively and prospectively. Various types of malperfusion syndromes were present in 26.7% of patients. The organ systems with malperfusion were as follows: cardiac, 7.2%; cerebral, 7.2%; ileofemoral, 12.7%; renal, 4.1%; mesenteric, 1.4%; innominate, 5.4%; and spine, 2.2%.
RESULTS: Coronary malperfusion required coronary revascularization in 62.5% of cases. Distal revascularization was needed in 42.9% of patients with ileofemoral malperfusion. Patients with malperfusion were more likely to suffer perioperative myocardial infarction (p<0.001), postoperative coma (p=0.012), delirium (p=0.011), sepsis (p=0.006), acute renal failure (p=0.017), dialysis (p=0.018), and acute limb ischemia (p<0.001). The in-hospital mortality was 30.5% in patients presenting with any malperfusion syndrome while only 6.2% in patients without malperfusion syndrome (p<0.001). Both cardiac (p=0.020) and cerebral malperfusions (p<0.001) were risk factors for in-hospital mortality. The actuarial long-term survival in patients with malperfusion syndrome was estimated by Kaplan-Meier methods to be 67.8%+/-6.1% at 1 year, 54.0%+/-7.0% at 5 years, and 43.1%+/-8.0% at 10 years and for patient without malperfusion 82.7%+/-3.0% at 1 year, 66.3%+/-3.9% at 5 years, and 46.1%+/-6.7% at 10 years (log rank 2.55, p=0.110). Cerebral malperfusion was a significant risk factor for decreased long-term survival (p=0.0002).
CONCLUSIONS: The occurrence of malperfusion in patients with acute type A dissection is associated with significant increased risk of in-hospital mortality and complications. Additional revascularization is generally needed in patients with coronary malperfusion and ileofemoral malperfusion. Patients presenting with cardiac and cerebral malperfusions have a high hospital mortality and preoperative cerebral malperfusion is associated with dismal long-term survival.

Entities:  

Mesh:

Year:  2007        PMID: 17500002     DOI: 10.1016/j.ejcts.2007.04.012

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  54 in total

1.  How to do it: direct true lumen cannulation technique of the ascending aorta in acute aortic dissection type A.

Authors:  Lars O Conzelmann; Ernst Weigang; Uwe Mehlhorn; Christian F Vahl
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-28

2.  Delayed visceral malperfusion after Bentall procedure for type A acute aortic dissection.

Authors:  Satoshi Yamashiro; Yukio Kuniyoshi; Yuya Kise; Ryoko Arakaki
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-09

3.  Analysis of early and long-term outcomes of acute type A aortic dissection according to the new international aortic arch surgery study group recommendations.

Authors:  Andrea Colli; Massimiliano Carrozzini; Marco Galuppo; Marina Comisso; Francesca Toto; Dario Gregori; Gino Gerosa
Journal:  Heart Vessels       Date:  2015-11-17       Impact factor: 2.037

4.  Strategies in the surgical treatment of type A aortic arch dissection.

Authors:  Jehangir J Appoo; Zlatko Pozeg
Journal:  Ann Cardiothorac Surg       Date:  2013-03

5.  We should replace the aortic arch and more in DeBakey type I dissection - A perspective from the Cleveland Clinic.

Authors:  Eric E Roselli
Journal:  Ann Cardiothorac Surg       Date:  2013-03

6.  [German Registry for Acute Aortic Dissection Type A (GERAADA): initial results].

Authors:  L O Conzelmann; T Krüger; I Hoffmann; B Rylski; J Easo; M Oezkur; K Kallenbach; O Dapunt; M Karck; E Weigang
Journal:  Herz       Date:  2011-09       Impact factor: 1.443

Review 7.  [Hybrid room technology as a prerequisite for the modern therapy of aortic dissection].

Authors:  H Jakob; K Tsagakis; D S Dohle; E Kottenberg; T Konorza; R A Janosi; R Erbel
Journal:  Herz       Date:  2011-09       Impact factor: 1.443

8.  Malperfusion in type A aortic dissection: results of emergency central aortic repair.

Authors:  Koji Kawahito; Naoyuki Kimura; Atsushi Yamaguchi; Kei Aizawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-07

Review 9.  Management of type A dissection with malperfusion.

Authors:  Bo Yang; Himanshu J Patel; David M Williams; Narasimham L Dasika; G Michael Deeb
Journal:  Ann Cardiothorac Surg       Date:  2016-07

10.  IRAD experience on surgical type A acute dissection patients: results and predictors of mortality.

Authors:  Paolo Berretta; Himanshu J Patel; Thomas G Gleason; Thoralf M Sundt; Truls Myrmel; Nimesh Desai; Amit Korach; Antonello Panza; Joe Bavaria; Ali Khoynezhad; Elise Woznicki; Dan Montgomery; Eric M Isselbacher; Roberto Di Bartolomeo; Rossella Fattori; Christoph A Nienaber; Kim A Eagle; Santi Trimarchi; Marco Di Eusanio
Journal:  Ann Cardiothorac Surg       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.